Top compounds associated with response to CISD1


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC -0.17 0.004
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.085 0.004
mRNA niclosamide CTRPv2 pan-cancer AAC 0.1 0.004
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.094 0.005
mRNA Rapamycin gCSI pan-cancer AAC 0.15 0.005
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.1 0.007
mRNA CP466722 GDSC1000 pan-cancer AAC -0.078 0.007
Download CSV